High serum galectin-3 in advanced melanoma: preliminary results.
about
Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surfaceTumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attackSoluble IgE receptors--elements of the IgE network.25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and ProgressionChemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis.Altered tumor-cell glycosylation promotes metastasis.Galectin-3 and the skinGalectins as cancer biomarkers.Tumor-associated galectin-3 modulates the function of tumor-reactive T cells.Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells.Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis.Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis.Association between circulating galectin-3 levels and the immunological, inflammatory and nutritional parameters in patients with colorectal cancerRole of galectins in lung cancer.Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells.Galectin-3 Serum Levels Could Help Clinicians Screen for Salivary Gland Tumor PatientsPeanut agglutinin appearance in the blood circulation after peanut ingestion mimics the action of endogenous galectin-3 to promote metastasis by interaction with cancer-associated MUC1.Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma.Gene expression profile of B 16(F10) murine melanoma cells exposed to hypoxic conditions in vitro.
P2860
Q28255527-C097B474-B805-426D-875E-D469276C9A5BQ34580297-246C5310-8449-4E9B-969E-B7022F382680Q35491143-155C4280-C3E4-46B5-A6B2-0B94B3FE04BCQ36173268-B41CB3F6-571D-4A19-A1F9-A9123379137EQ36414261-207AB57F-9FFA-43A9-BF4D-39027BFB8E34Q37581540-69D543FB-2652-422B-8227-CF050EFC73A6Q37926145-07CE05A9-E2F0-45B6-89B0-A4AED985A706Q38105320-EEABB6F0-8614-4FFE-A1C9-E9D99B43986BQ38572896-9B839CA4-923D-4326-BF7D-10465CA64811Q38800444-408FEC59-8685-44C8-AA46-DB26588D2685Q39359190-67797345-E1D1-4F69-9597-A37BE51A2128Q39690197-D1433C6B-7645-4D91-81CB-6294B93C6A23Q39805251-7B6F9DE5-1267-4033-B3CC-24C55DE8ECA7Q42177420-64687F75-C7A4-46D4-97A3-C75B536FAD6CQ47108427-C4DB206E-3779-4000-A3F3-4500E0D274F5Q48270428-A01A031A-C39E-4D44-9C74-9E1DCB62881EQ51079321-609101BE-F7A1-41F8-9297-20C77DCAD11EQ52630484-CC8F084A-7EDF-4685-BEDA-6FEB3394805BQ53229242-F9608069-DF9F-470B-B999-FDEBCDE53871Q55119445-90EBA8FD-1E9C-499B-8B9C-EC7D6E5D795DQ55519456-C171D978-BD30-41BE-906B-BA1C9B449B8E
P2860
High serum galectin-3 in advanced melanoma: preliminary results.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
High serum galectin-3 in advanced melanoma: preliminary results.
@en
High serum galectin-3 in advanced melanoma: preliminary results.
@nl
type
label
High serum galectin-3 in advanced melanoma: preliminary results.
@en
High serum galectin-3 in advanced melanoma: preliminary results.
@nl
prefLabel
High serum galectin-3 in advanced melanoma: preliminary results.
@en
High serum galectin-3 in advanced melanoma: preliminary results.
@nl
P2093
P2860
P1476
High serum galectin-3 in advanced melanoma: preliminary results.
@en
P2093
Legssyer I
Vanhaeverbeek M
Vereecken P
Zouaoui Boudjeltia K
P2860
P304
P356
10.1111/J.1365-2230.2005.01992.X
P577
2006-01-01T00:00:00Z